Earendil Labs

News

Earendil has raised an impressive $787m in financing for its AI-powered drug platform, attracting yet more buy-in from Sanofi.

News

Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia, a DTx called Motivista.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.